It binds to GLP-1 receptors in the beta cells of the pancreas to promote insulin secretion and is used as a drug to aid in the treatment of diabetes in adults with type 2 diabetes who are obese due to overeating or overweight in the pre-diabetic population
Infections involving pathogenic bacteria, parasites, or viruses can also disrupt your gut microbe balance and lead to inflammation and permeability in the intestines
Summary Although GLP-1R agonists were originally developed for glycemic control in DM, their mechanistic versatility has enabled broader application across a spectrum of cardiovascular, cerebrovascular and metabolic disorders
It is promoted as an anti-ageing drug
Depending on an individuals response and as advised by the doctor, the dosage may be incrementally increased
No insurance required, no prior authorization, no appeal process